Application Nr Approved Date Route Status External Links
ANDA075511 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Famotidine Tablets Are Indicated In Adult And Pediatric Patients 40 Kg And Greater For The Treatment Of: Active Duodenal Ulcer (du). Active Gastric Ulcer (gu). Symptomatic Nonerosive Gastroesophageal Reflux Disease (gerd). Erosive Esophagitis Due To Gerd, Diagnosed By Biopsy. Famotidine Tablets Are Indicated In Adults For The: Treatment Of Pathological Hypersecretory Conditions (e.g., Zollinger-Ellison Syndrome, Multiple Endocrine Neoplasias). Reduction Of The Risk Of Duodenal Ulcer Recurrence. Famotidine Tablets Are A Histamine-2 (h 2 ) Receptor Antagonist Indicated (1 ): In Adult And Pediatric Patients 40 Kg And Greater For The Treatment Of: Active Duodenal Ulcer (du). Active Gastric Ulcer. Symptomatic Nonerosive Gastroesophageal Reflux Disease (gerd). Erosive Esophagitis Due To Gerd, Diagnosed By Biopsy. In Adults For The: Treatment Of Pathological Hypersecretory Conditions (e.g., Zollinger-Ellison Syndrome, Multiple Endocrine Neoplasias). Reduction Of The Risk Of Du Recurrence.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Famotidine FAMOTIDINE ZINC1530636

Comments